	Gangliosides in Cutaneous Melanoma: Molecular Mechanisms, Translational Evidence Gaps, and Preclinical Natural-Compound Leads. Int J Mol Sci Koo DB, Kim K, Kim J, Yun HG, Song EB, Kim MY, Ryu JS, Kim JS, Kim S, Lee HA, Choo YK. PMID: 42941795 [PubMed - as supplied by publisher]
	Changes in Quality of Life After Treatment for Non-Melanoma Skin Cancer: A Prospective Cohort Study. J Clin Med Öztürk F, Bacak ZNU, , , Aydo, Yazici S, Çeçen S, Cengiz Özyurt B, Sar. PMID: 42941405 [PubMed - as supplied by publisher]
	Clinical Utility of 18F-FDG PET/CT for Staging and Restaging of Pediatric Malignant Melanoma: A Single-Center Retrospective Study. Children (Basel) Isik EG, Kebudi R. PMID: 42940747 [PubMed]
	Lymphatic Microvascular Density, Lymphatic Invasion and Endothelial Cell Proliferation as Prognostic Biomarkers in Cutaneous Melanoma: A Systematic Review and Evidence Map. Cancers (Basel) Dumitrascu VC, Ceau, Mitule, Muntean C, Popescu R, Dumitrescu G, Gaje PN, Raica M, Vlad CS. PMID: 42938944 [PubMed]
	Reprogramming the Melanoma Tumor Microenvironment: From Cellular Crosstalk to Cellular Immunotherapy. Cancers (Basel) Jumaniyazova E, Gantsova E, Kazarian G, Charyeva I, Fatkhudinov T. PMID: 42938860 [PubMed]
	Survival Outcomes of Patients With Melanoma Treated With Mohs Micrographic Surgery: A Systematic Review and Meta-Analysis. Dermatol Surg Caraviello C, Al-Kutubi H, Daré Agrizzi L, Ferraz M, Aktas S, Hirata SH, Tomimori J. PMID: 42937688 [PubMed - as supplied by publisher]
	Tebentafusp induces systemic immune activation, but tumor immune remodeling remains incompletely validated: a narrative review in metastatic uveal melanoma. Front Immunol Rifaldi F, De Braud F, Del Vecchio M, Di Guardo L. PMID: 42935816 [PubMed - indexed for MEDLINE]
	Safety and efficacy of dual immune checkpoint inhibition for melanoma brain metastases and its comparison to ICI monotherapy: A systematic review and meta-analysis. Neurosurg Rev Shariati A, Mehrtabar E, Fanihagh T, Moghaddam R, Delbari P, Mehrtabar S, Ghalehtaki R. PMID: 42934318 [PubMed - indexed for MEDLINE]
	Exploring Geiger Count Thresholds for Sentinel Node Identification in Melanoma: Is 10 % Still Optimal? Ann Surg Oncol Mukherjee TJ, Hagenson RA, Brown LM, Baumann RP Jr, Ariyan S, Olino KL, Clune JE. PMID: 42932113 [PubMed - as supplied by publisher]
	NRAS Mutations in Different Melanoma Histotypes: Molecular and Clinical Implications. Curr Oncol Rep Pisano M, Tore S, Demartis S, Dallocchio RN, Casula S, Colombino M, Manca A, Usai M, Nuvoli L, Palmieri G, Casula M. PMID: 42931977 [PubMed - indexed for MEDLINE]
	Diagnosis and Surgical Treatment of Acral Lentiginous Melanoma on Third Toe of 57-Year-Old Male: A Case Report. J Am Podiatr Med Assoc Janeczko C, Sims E, Nitzkorski JR. PMID: 42931042 [PubMed - indexed for MEDLINE]
	MicroRNAs in Cutaneous Melanoma: Biological Roles, Clinical Utility, and Future Directions. Med Sci (Basel) Pa, Muntean MV, Gherman CD, Gâta VA, , Halmágyi SR, Ungureanu L. PMID: 42930517 [PubMed - indexed for MEDLINE]
	A Dual-Stream Feature Learning Framework with Adaptive Bio-Inspired Protozoa-Starfish Optimization for Melanoma Classification. Biomimetics (Basel) Jayasankar S, Brindha T. PMID: 42930253 [PubMed]
	Induction Systemic Therapy Followed by Response-Adapted Consolidative Radiation in Locally Advanced Non-Melanoma Skin Cancer: A Retrospective Case Series. Curr Oncol Vaidya P, Azenkot T, Bliamptis J, Victor MT, Dornisch A, Chang J, Sanghvi P, Guo T, Park SJ. PMID: 42930169 [PubMed - indexed for MEDLINE]
	Carboxymethylcellulose/Hyaluronic Acid Hybrid Nanoconjugates: Toward Multifunctional Platforms for Melanoma Skin Cancer Theranostics. Gels Miranda DV, Mansur AAP, Mansur HS, Carvalho IC. PMID: 42929909 [PubMed]
	Multi-Analyte Responsive Fluorescent Sensing of Pathological Cellular States in Melanoma. Methods Mol Biol Altves S, Sahin E, Erbas-Cakmak S. PMID: 42926278 [PubMed - indexed for MEDLINE]
	Design Strategies for Melanoma-Targeting Fluorescent Probes. Methods Mol Biol Sahin E, Altves S, Erbas-Cakmak S. PMID: 42926277 [PubMed - indexed for MEDLINE]
	Model Systems for the Study of Malignant Melanoma. Methods Mol Biol Reed S, Gregg RK. PMID: 42926260 [PubMed - indexed for MEDLINE]
	Relatlimab plus nivolumab versus nivolumab for advanced melanoma: 5-year survival and biomarker analyses of the phase 3 RELATIVITY-047 trial. Nat Med Long GV, Dolfi S, Hodi FS, Lipson EJ, Schadendorf D, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Fecher LA, Lao CD, De Menezes JJ, Dalle S, Arance A, Gaudy-Marqueste C, Murillo E, Maio M, Rohde M, Garnett-Benson C, Jiang R, Chen B, Yu JX, Hollmann T, Zuchtriegel G, Tawbi H. PMID: 42926136 [PubMed - as supplied by publisher]
	Single-Stage excision and sentinel lymph node biopsy in selected patients with cutaneous melanoma: a monocentric retrospective cohort study. Melanoma Res Bruno S, Nacchiero E, Ronghi V, Elia R, Giudice G. PMID: 42924894 [PubMed - as supplied by publisher]

Articles 1 - 20 / 46512

Page 1 of 2326



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy